Internet-based Cognitive-behavioral Treatment for Insomnia in COPD Patients Undergoing Pulmonary Rehabilitation
Enhancing Pulmonary Rehabilitation in Veterans With Chronic Obstructive Pulmonary Disease Through Internet-based Cognitive-behavioral Treatment for Insomnia
1 other identifier
interventional
13
1 country
2
Brief Summary
This study is a randomized controlled trial (RCT) to compare sleep and health-related functioning in Veterans with chronic obstructive pulmonary disease (COPD) and insomnia receiving an Internet-based behavioral treatment for insomnia versus online insomnia patient education. Participants will undergo a sleep and health assessment that will be performed at baseline, post-treatment, and 3-months later. Participants will be randomly assigned to either Internet-based behavioral treatment for insomnia or online insomnia patient education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease
Started Feb 2022
Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 4, 2021
CompletedFirst Posted
Study publicly available on registry
January 7, 2021
CompletedStudy Start
First participant enrolled
February 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedResults Posted
Study results publicly available
April 17, 2026
CompletedApril 17, 2026
April 1, 2026
3.1 years
January 4, 2021
March 17, 2026
April 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Insomnia Severity Index (ISI)
The ISI is a 7-item self-report questionnaire assessing nature, severity and impact of insomnia symptoms. The total score ranges from 0 to 28, with higher scores indicating worse insomnia severity.
Baseline to 3-months post-treatment
St. George's Respiratory Questionnaire (SGRQ)
The SGRQ is a 50-item measure assessing disease-specific quality of life. The total SGRQ score, which reflects the overall impact of the disease on quality of life, ranges from 0 to 100, with higher scores indicating greater impairment.
Baseline to 3-months post-treatment
Study Arms (2)
Internet-based behavioral treatment for insomnia
EXPERIMENTALInternet version of cognitive-behavioral treatment for insomnia
Online insomnia patient education
EXPERIMENTALOnline insomnia patient education
Interventions
Internet version of cognitive-behavioral treatment for insomnia
Online insomnia patient education
Eligibility Criteria
You may qualify if:
- Age 40 years and older
- Primary diagnosis of COPD defined by GOLD
- Meets criteria for Insomnia Disorder
- At least moderate insomnia severity based on Insomnia Severity Index score \>7
- Stable psychiatric and medical conditions
- Must have telephone, email, and reliable Internet access via computer, smartphone, or tablet
You may not qualify if:
- Untreated current major depression
- Serious suicidal risk
- Substance abuse disorder within past 3 months
- History of bipolar or psychosis
- Untreated restless legs syndrome, delayed sleep phase syndrome, irregular sleep schedules
- Very severe untreated obstructive sleep apnea
- Severe excessive daytime sleepiness based on Epworth Sleepiness Scale score \> 16
- Restrictive lung disease (FEV1/FVC 70 and FEV1 \< 80% predicted) or asthma
- Plans to move during the following 6 months
- Non-English speaking or sensory deficits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
John D. Dingell VA Medical Center, Detroit, MI
Detroit, Michigan, 48201-1916, United States
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, Pennsylvania, 15240, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The study did not reach the target number of participants needed to achieve target power and statistically reliable results.
Results Point of Contact
- Title
- Faith Luyster
- Organization
- VA Pittsburgh Healthcare System
Study Officials
- PRINCIPAL INVESTIGATOR
Faith S Luyster, PhD
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessor will be blinded to group assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 4, 2021
First Posted
January 7, 2021
Study Start
February 14, 2022
Primary Completion
March 31, 2025
Study Completion
June 30, 2025
Last Updated
April 17, 2026
Results First Posted
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share